Home
>
National Drug Code (NDC)
>
FELODIPINEEXTENDED-RELEASE TABLETS
FELODIPINEEXTENDED-RELEASE TABLETS - 63304-435-01 - (felodipine)
Drug Information of FELODIPINEEXTENDED-RELEASE TABLETS
| Product NDC: | 63304-435 |
| Proprietary Name: | FELODIPINEEXTENDED-RELEASE TABLETS |
| Non Proprietary Name: | felodipine |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; felodipine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of FELODIPINEEXTENDED-RELEASE TABLETS
| Product NDC: | 63304-435 |
| Labeler Name: | Ranbaxy Pharmaceuticals Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019834 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080910 |
Package Information of FELODIPINEEXTENDED-RELEASE TABLETS
| Package NDC: | 63304-435-01 |
| Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-435-01) |
NDC Information of FELODIPINEEXTENDED-RELEASE TABLETS
| NDC Code | 63304-435-01 |
| Proprietary Name | FELODIPINEEXTENDED-RELEASE TABLETS |
| Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-435-01) |
| Product NDC | 63304-435 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | felodipine |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080910 |
| Marketing Category Name | NDA |
| Labeler Name | Ranbaxy Pharmaceuticals Inc |
| Substance Name | FELODIPINE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
